Pfizer Inc. is recalling 338,540 bags of Milrinone Lactate Injection 200 mcg/mL (0.2 mg/mL) in 5% Dextrose, including both 100 mL and 200 mL sizes. These Hospira brand products are being recalled because the bags have the potential to leak, which means the sterility of the medication cannot be guaranteed. This issue was discovered after the firm initiated a voluntary notification via letter to affected customers.
A leaking IV bag compromises the sterile barrier of the medication, which can lead to contamination. Administering a non-sterile injectable drug directly into the bloodstream poses a significant risk of serious infection or other life-threatening complications.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.